The Application of the DMAIC approach of Lean Six Sigma in the optimization of response time to urgent requests in a medical analysis laboratory: Case study

Authors

  • Mohamed OMARI Hassan II University

DOI:

https://doi.org/10.55897/ijpo.2023.01.08

Keywords:

Lean Six Sigma, medical analysis laboratory, continuous improvement, DMAIC.

Abstract

Similar to large companies, entrepreneurs would exploit modern management methods to improve their processes, performance and competitiveness.

Lean Six Sigma is a management approach dedicated to production organizations. It takes into account their specificity and seems to be appropriate to achieve the assigned objectives.

Medical laboratories have complex production processes, and Lean Six Sigma could improve them by using the DMAIC approach. The DMAIC approach is divided into five steps: define measure, analyze, innovate, and control; besides it is used to organize the sample handling production processes in medical laboratories.

The application of the DMAIC of Lean Six Sigma in our case has allowed us to identify problems, define the actions to eliminate failures and to monitor the effectiveness of these actions to measure the performance of our action plan.

We have improved the management of samples in the laboratory by prioritizing urgent samples in order to reduce their turnaround time, by directing them into the emergency track. This action has brought a significant reduction in the time between receiving simple to validation step of the results, with a clear improvement in turnover and the number of requests and analyses in the laboratory over the last two years.

Downloads

Download data is not yet available.

Downloads

Published

2023-06-11 — Updated on 2023-06-11

Versions

How to Cite

OMARI, M. (2023). The Application of the DMAIC approach of Lean Six Sigma in the optimization of response time to urgent requests in a medical analysis laboratory: Case study. International Journal of Performance and Organizations, 2(1), 72–82. https://doi.org/10.55897/ijpo.2023.01.08